Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Year in review: An IPO a day in 2014
At least 369 companies filed for initial public offerings last year, a 44% increase over 2013, and the medical device industry was no exception.
Thirty-one medtech companies decided to test the public markets last year, according to a MassDevice.com analysis, with 21 closing on a collective $1.34 billion. Read more
2. Covidien’s Stellarex drug-eluting balloon wins CE Mark
European regulators granted market clearance for Covidien’s Stellarex drug-eluting balloon for treating peripheral artery disease, the company said.
Covidien is due to sell the Stellarex assets to Spectranetics as soon as its $43 billion merger with Medtronic closes, which is expected to occur later this month or in early February. Read more
1. Hatch renews commitment to medical device tax repeal
One of Medtech’s BFFs on Capitol Hill is now a BMOC too.
Sen. Orrin Hatch (R-Utah) yesterday was sworn in as chairman of the Senate Finance Committee and named president pro tempore, making him 1 of the most powerful men in the U.S. government. The 80-year-old Utah lawmaker is now 3rd in line for the presidency, after the vice president and speaker of the U.S. House of Representatives. Read more
